LAURUS LABS
Back to Balance Sheet
|
LAURUS LABS Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹3,112 Cr | ₹2,432 Cr | ₹2,681 Cr | ₹2,457 Cr | ₹1,692 Cr |
What is the latest Total Current Liabilities ratio of LAURUS LABS ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹3,112 Cr |
Mar2023 | ₹2,432 Cr |
Mar2022 | ₹2,681 Cr |
Mar2021 | ₹2,457 Cr |
Mar2020 | ₹1,692 Cr |
How is Total Current Liabilities of LAURUS LABS Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹3,112 Cr | 27.96 | |
Mar2023 | ₹2,432 Cr | -9.28 | |
Mar2022 | ₹2,681 Cr | 9.11 | |
Mar2021 | ₹2,457 Cr | 45.19 | |
Mar2020 | ₹1,692 Cr | - |
Compare Total Current Liabilities of peers of LAURUS LABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LAURUS LABS | ₹30,980.1 Cr | -6.4% | 5.4% | 49.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹410,142.0 Cr | -1.5% | 9.1% | 9.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹145,762.0 Cr | -4.9% | -0.6% | 59.1% | Stock Analytics | |
CIPLA | ₹114,322.0 Cr | -1.8% | 1% | 0.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹111,171.0 Cr | 1.6% | 12.1% | 21.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹92,603.7 Cr | -3% | -0.9% | -7.7% | Stock Analytics |
LAURUS LABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LAURUS LABS | -6.4% |
5.4% |
49.4% |
SENSEX | -2.9% |
3.1% |
1.8% |
You may also like the below Video Courses